Caladrius Biosciences Provides Corporate Update and Reports 2020 First Quarter Financial Results

NEXT STORY
Coherus BioSciences Reports First Quarter 2020 Financial Results
PREV STORY
Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Clearside Biomedical Announces Completion of Patient Enrollment in First of Two Phase 3 Clinical Trials of CLS-TA in Retinal Vein Occlusion

ALPHARETTA, Ga., June 13, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical ...

author_avatar
NASDAQ Market News

RedHill Biopharma Increases Patient Access to Talicia® with EnvisionRx Formularies

author_avatar
NASDAQ Market News

Protech Home Medical Invited to Present at the MicroCap Rodeo Best Ideas Bowl on October 13th to 16th

author_avatar
NASDAQ Market News